Report post
Bayer's acquisition of Monsanto has been fraught with challenges, including public backlash over the controversial herbicide Glyphosate. Despite offering $62 billion, Bayer struggles to turn around the toxic deal. DW News reports on Bayer's difficulties and Monsanto's lobbying efforts surrounding Glyphosate. The acquisition has become a disaster for Bayer, highlighting the risks of large-scale mergers in the agricultural industry.

The World's Leading Crypto Trading Platform

Get my welcome gifts